CN Patent

CN108299279B — 取代芳基胺醇化合物及其制备方法和用途

Assigned to Beijing Merson Pharmaceutical Co ltd · Expires 2021-03-23 · 5y expired

What this patent protects

本发明涉及式(I)的化合物或其药学上可接受的盐,其中:Ar是芳基,杂芳基,或者被一个或多个C 1 ‑C 6 烷基、卤素、羟基、胺基、巯基、芳基、杂环基取代的芳基或杂芳基;X是O、NH或者S;R是C 1 ‑C 4 脂肪烷基,或被卤素或苯基取代的C 1 ‑C 4 脂肪烷基;和n=1‑3。本发明还提供了式(I)的化合物或其药学上可接受的盐的制备方法和用途。本发明的化合物可用于血管瘤和/或脉管畸形的治疗。

USPTO Abstract

本发明涉及式(I)的化合物或其药学上可接受的盐,其中:Ar是芳基,杂芳基,或者被一个或多个C 1 ‑C 6 烷基、卤素、羟基、胺基、巯基、芳基、杂环基取代的芳基或杂芳基;X是O、NH或者S;R是C 1 ‑C 4 脂肪烷基,或被卤素或苯基取代的C 1 ‑C 4 脂肪烷基;和n=1‑3。本发明还提供了式(I)的化合物或其药学上可接受的盐的制备方法和用途。本发明的化合物可用于血管瘤和/或脉管畸形的治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN108299279B
Jurisdiction
CN
Classification
Expires
2021-03-23
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Merson Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.